+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cardiac Marker Testing Market Research Report by Product, by Type, by Disease, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4995396
  • Report
  • July 2021
  • Region: Global
  • 191 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Cardiac Marker Testing Market will Grow to USD 5,352.36 Million by 2026, at a CAGR of 8.61%

FEATURED COMPANIES

  • Abbott Laboratories
  • Biomérieux SA
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • LSI Medience Corporation
The Global Cardiac Marker Testing Market size was estimated at USD 3,260.43 Million in 2020 and expected to reach USD 3,530.19 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.61% to reach USD 5,352.36 Million by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Cardiac Marker Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the Cardiac Marker Testing Market was examined across Instruments and Reagents and Kits. The Instruments was further studied across Chemiluminescence, Elisa, Immunochromatography, and Immunofluorescence.
  • Based on Type of Testing, the Cardiac Marker Testing Market was examined across Laboratory Testing and Point-Of-Care Testing.
  • Based on Type, the Cardiac Marker Testing Market was examined across Bnp Or Nt-Probnp, CK-MB, Hscrp, Myoglobin, and Troponin I and T.
  • Based on Disease, the Cardiac Marker Testing Market was examined across Congestive Heart Failure and Myocardial Infarction.
  • Based on Geography, the Cardiac Marker Testing Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas was further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific was further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa was further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cardiac Marker Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cardiac Marker Testing Market, including Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomérieux SA, bioMérieux SA, Danaher Corporation, DiaSorin S.p.A., Guangzhou Wondfo Biotech Co., Ltd, LSI Medience Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Randox laboratories Ltd., Roche Diagnostics Ltd., Siemens Healthineers AG, and Thermo Fisher Scientific Inc. Tosoh Corporation (Japan).

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cardiac Marker Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cardiac Marker Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cardiac Marker Testing Market?
4. What is the competitive strategic window for opportunities in the Global Cardiac Marker Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Cardiac Marker Testing Market?
6. What is the market share of the leading vendors in the Global Cardiac Marker Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Cardiac Marker Testing Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Biomérieux SA
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • LSI Medience Corporation
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Type of Testing Outlook
3.5. Type Outlook
3.6. Disease Outlook
3.7. Geography Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of cardiovascular diseases
5.1.1.2. Rapidly increasing geriatric population and the subsequent increase of the burden of heart diseases on the healthcare system worldwide
5.1.1.3. Attractive funding from public and private organizations for research on cardiac biomarkers
5.1.2. Restraints
5.1.2.1. Technical difficulty related to sample collection and storage
5.1.3. Opportunities
5.1.3.1. Clinical trials for the identification of novel cardiac biomarkers
5.1.3.2. Point-of-care testing (POCT) with cardiac biomarkers
5.1.4. Challenges
5.1.4.1. Loosely defined reimbursement systems
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Cardiac Marker Testing Market, by Product
6.1. Introduction
6.2. Instruments
6.2.1. Chemiluminescence
6.2.2. Elisa
6.2.3. Immunochromatography
6.2.4. Immunofluorescence
6.3. Reagents and Kits

7. Cardiac Marker Testing Market, by Type of Testing
7.1. Introduction
7.2. Laboratory Testing
7.3. Point-Of-Care Testing

8. Cardiac Marker Testing Market, by Type
8.1. Introduction
8.2. Bnp Or Nt-Probnp
8.3. CK-MB
8.4. Hscrp
8.5. Myoglobin
8.6. Troponin I and T

9. Cardiac Marker Testing Market, by Disease
9.1. Introduction
9.2. Congestive Heart Failure
9.3. Myocardial Infarction

10. Americas Cardiac Marker Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Cardiac Marker Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Thailand

12. Europe, Middle East & Africa Cardiac Marker Testing Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Abbott Laboratories
14.2. Becton, Dickinson and Company
14.3. Bio-Rad Laboratories, Inc.
14.4. Biomérieux SA
14.5. bioMérieux SA
14.6. Danaher Corporation
14.7. DiaSorin S.p.A.
14.8. Guangzhou Wondfo Biotech Co., Ltd
14.9. LSI Medience Corporation
14.10. Ortho Clinical Diagnostics
14.11. PerkinElmer Inc.
14.12. Randox laboratories Ltd.
14.13. Roche Diagnostics Ltd.
14.14. Siemens Healthineers AG
14.15. Thermo Fisher Scientific Inc. Tosoh Corporation (Japan)

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2020 (USD MILLION)
FIGURE 4. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2020 (USD MILLION)
FIGURE 6. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL CARDIAC MARKER TESTING MARKET: MARKET DYNAMICS
FIGURE 9. GLOBAL CARDIAC MARKER TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 10. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 11. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2026
FIGURE 13. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CHEMILUMINESCENCE, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CHEMILUMINESCENCE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY ELISA, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY ELISA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS AND KITS, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS AND KITS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2020 VS 2026 (%)
FIGURE 26. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2020 VS 2026 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2026
FIGURE 28. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LABORATORY TESTING, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LABORATORY TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 33. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2026
FIGURE 35. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BNP OR NT-PROBNP, 2018-2026 (USD MILLION)
FIGURE 36. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BNP OR NT-PROBNP, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 37. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CK-MB, 2018-2026 (USD MILLION)
FIGURE 38. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CK-MB, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 39. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HSCRP, 2018-2026 (USD MILLION)
FIGURE 40. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HSCRP, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 41. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOGLOBIN, 2018-2026 (USD MILLION)
FIGURE 42. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOGLOBIN, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 43. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I AND T, 2018-2026 (USD MILLION)
FIGURE 44. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I AND T, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 45. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2020 VS 2026 (%)
FIGURE 46. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2020 VS 2026 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2026
FIGURE 48. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CONGESTIVE HEART FAILURE, 2018-2026 (USD MILLION)
FIGURE 49. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 50. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOCARDIAL INFARCTION, 2018-2026 (USD MILLION)
FIGURE 51. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOCARDIAL INFARCTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 52. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 53. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 55. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 56. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 57. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 58. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 59. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 60. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 61. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 63. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 64. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 65. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 66. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 67. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 68. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 69. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 70. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 71. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 72. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 74. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 75. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 76. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 77. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 78. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 79. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 80. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 81. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 82. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 83. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 84. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 85. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 86. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 87. GLOBAL CARDIAC MARKER TESTING MARKET: FPNV POSITIONING MATRIX
FIGURE 88. GLOBAL CARDIAC MARKER TESTING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 89. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CARDIAC MARKER TESTING MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL CARDIAC MARKER TESTING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CHEMILUMINESCENCE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY ELISA, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHY, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS AND KITS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LABORATORY TESTING, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BNP OR NT-PROBNP, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CK-MB, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HSCRP, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOGLOBIN, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I AND T, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOCARDIAL INFARCTION, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 23. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 24. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 25. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 26. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 27. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 28. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 29. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 30. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 31. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 32. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 33. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 34. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 35. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 36. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 37. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 38. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 39. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 40. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 41. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 42. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 43. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 44. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 45. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 46. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 47. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 48. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 49. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 50. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 51. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 52. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 53. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 54. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 55. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 56. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 57. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 58. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 59. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 60. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 61. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 62. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 63. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 64. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 65. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 66. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 67. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 68. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 69. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 70. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 71. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 72. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 73. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 74. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 75. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 76. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 77. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 78. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 79. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 80. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 81. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 82. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 83. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 84. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 85. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 86. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 87. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 88. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 89. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 90. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 91. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 92. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 93. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 99. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 100. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 101. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 102. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 103. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 104. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 105. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 106. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 107. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 108. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 109. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 110. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 111. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 112. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 113. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 114. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 115. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 116. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 117. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 118. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 119. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 120. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 121. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 122. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 123. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 124. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 125. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 126. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 127. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 128. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 129. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 130. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 131. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 132. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 133. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 134. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 139. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 140. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2026 (USD MILLION)
TABLE 141. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 142. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2026 (USD MILLION)
TABLE 143. GLOBAL CARDIAC MARKER TESTING MARKET: SCORES
TABLE 144. GLOBAL CARDIAC MARKER TESTING MARKET: BUSINESS STRATEGY
TABLE 145. GLOBAL CARDIAC MARKER TESTING MARKET: PRODUCT SATISFACTION
TABLE 146. GLOBAL CARDIAC MARKER TESTING MARKET: RANKING
TABLE 147. GLOBAL CARDIAC MARKER TESTING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 148. GLOBAL CARDIAC MARKER TESTING MARKET: MERGER & ACQUISITION
TABLE 149. GLOBAL CARDIAC MARKER TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 150. GLOBAL CARDIAC MARKER TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 151. GLOBAL CARDIAC MARKER TESTING MARKET: INVESTMENT & FUNDING
TABLE 152. GLOBAL CARDIAC MARKER TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 153. GLOBAL CARDIAC MARKER TESTING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomérieux SA
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Guangzhou Wondfo Biotech Co., Ltd
  • LSI Medience Corporation
  • Ortho Clinical Diagnostics
  • PerkinElmer Inc.
  • Randox laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc. Tosoh Corporation (Japan)
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll